Unites States Real World Evidence Solution Market Research Report to 2027 – by Component, Therapeutic Area, End-User and State – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Real World Evidence Solution Market Research Report by Component, by Therapeutic Area, by End-User, by State – United States Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering.

The United States Real World Evidence Solution Market size was estimated at USD 192.43 million in 2020, is expected to reach USD 213.44 million in 2021, and is projected to grow at a CAGR of 12.91% to reach USD 450.29 million by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Real World Evidence Solution Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Real World Evidence Solution Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the United States Real World Evidence Solution Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Real World Evidence Solution Market?

4. What is the competitive strategic window for opportunities in the United States Real World Evidence Solution Market?

5. What are the technology trends and regulatory frameworks in the United States Real World Evidence Solution Market?

6. What is the market share of the leading vendors in the United States Real World Evidence Solution Market?

7. What modes and strategic moves are considered suitable for entering the United States Real World Evidence Solution Market?

Market Dynamics

Drivers

• Growing number of RWE service providers
• Increasing number of pharmaceutical companies adopting RWE for drug approval processes

Restraints

• Reluctance to rely on real-world studies

Opportunities

• Support from regulatory bodies for the use of RWE solutions
• Rising focus on end-to-end RWE services

Challenges

• Lack of universally accepted methodological standards and data processing infrastructure

Companies Mentioned

• Certara, L.P.
• Clinigen Group PLC
• Cognizant Technology Solutions Corp.
• HealthiVibe, LLC
• IBM Corporation
• ICON PLC
• IQVIA
• Mercy Technology Services
• Oracle Corporation
• PAREXEL International Corporation
• Pharmaceutical Product Development, LLC
• SAS Institute, Inc.
• Sciformix Corporation
• Syneos Health
• Turacoz

For more information about this report visit https://www.researchandmarkets.com/r/r89vc8

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900